Earlier this week, the Ohio Manufacturers’ Association (OMA) voiced strong support for Ohio employers by raising concerns about House Bill 276, which proposes an expansion of the federal 340B Drug Pricing Program.
OMA President Ryan Augsburger authored an op-ed in The Columbus Dispatch, and Managing Director of Public Policy James Lee testified before the House Insurance Committee, urging lawmakers to pause the bill. The proposed expansion would add $326 million in healthcare costs for Ohio employers. Moreover, a recent report from the Congressional Budget Office has shown that the program fails to deliver drug discounts to the low-income patients the program was meant to benefit. The OMA is advocating for transparency and accountability before any expansion — ensuring healthcare dollars truly benefit Ohioans, not drive-up premiums for businesses and employees.
The National Association of Manufacturers’ is leading the charge for necessary congressional reforms to place guardrails on the 340B Program and restore its original intent to protect patients, employers and rural healthcare systems. 10/14/2025